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Innate and adaptive immune responses depend 
on the activation of NF-B, which has five 
family members: RelA (p65), RelB, c-Rel, NF-
B1 (p50), and NF-B2 (p52; Hayden and Ghosh, 
2008, 2012; Napetschnig and Wu, 2013). NF-B 
dimers are retained in the cytoplasm by inhibi-
tors of NF-B (IBs), mainly IB in immune 
cells, which prevent the nuclear translocation 
of NF-B. In the canonical NF-B pathway, 
used by TLRs, CD40, and receptors for antigen, 
IL-1, TNF, and ectodysplasin A (EDA), receptor 
ligation causes activation of the IB kinase 
(IKK) complex, which consists of the NF-B 
essential modulator (NEMO/IKK) and the 
catalytic subunits IKK and IKK (Bonizzi 
and Karin, 2004). The activated IKK complex 
phosphorylates IB at Ser 32 and Ser 36, which 
targets it for polyubiquitination and degradation 
by the 26S proteasome (Karin and Ben-Neriah, 
2000). The released NF-B dimers (primarily 
p50/p65) translocate to the nucleus and activate 
transcription of genes encoding inflamma-
tory cytokines, chemokines, adhesion molecules, 
and IB itself (Hayden et al., 2006; Hayden 
and Ghosh, 2008). In the noncanonical path-
way, used by lymphotoxin  receptor (LTR), 
B cell activating factor receptor (BAFF-R), 
and CD40, NF-B–inducing kinase (NIK) ac-
tivates IKK, resulting in the phosphorylation 
of p100 (NF-B2), which is in complex with 
RelB in the cytoplasm. p100 then undergoes 
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Patients with ectodermal dysplasia with immunodeficiency (ED-ID) caused by mutations in 
the inhibitor of NF-B  (IB) are susceptible to severe recurrent infections, despite 
normal T and B cell numbers and intact in vitro lymphocyte function. Moreover, the out-
come of hematopoietic stem cell transplantation (HSCT) in these patients is poor despite 
good engraftment. Mice heterozygous for the IB S32I mutation found in patients exhib-
ited typical features of ED-ID. Strikingly, the mice lacked lymph nodes, Peyer’s patches, 
splenic marginal zones, and follicular dendritic cells and failed to develop contact hyper-
sensitivity (CHS) or form germinal centers (GCs), all features not previously recognized in 
patients and typical of defective noncanonical NF-B signaling. Lymphotoxin  receptor 
(LTR)–driven induction of chemokines and adhesion molecules mediated by both canonical 
and noncanonical NF-B pathways was impaired, and levels of p100 were markedly dimin-
ished in the mutant. IB mutant→Rag2/, but not WT→IB mutant, bone marrow 
chimeras formed proper lymphoid organs and developed CHS and GCs. Defective architec-
tural cell function explains the immunodeficiency and poor outcome of HSCT in patients 
with IB deficiency and suggests that correction of this niche is critical for reconstituting 
their immune function.
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were decreased in the IB mutant. Analysis of BM radiation 
chimeras demonstrated that the defective lymphoid organo-
genesis in the IB mutant is caused by a defect in nonhema-
topoietic cells, thus explaining the poor outcome of HSCT in 
patients with IB deficiency.
RESULTS
Mice heterozygous for the S32I mutation in IB have ED 
and impaired IB phosphorylation and degradation
The strategy for the generation and identification of the het-
erozygous IB S32I mutant (IB mutant) mice is shown 
in Fig. S1. IB mutant mice were born at the normal Men-
delian ratio but were significantly smaller in size and weight 
than their WT littermates (Fig. 1, A and B) and had a 50% 
survival rate at 8 wk compared with 100% for WT littermates 
(Fig. 1 C). IB mutant mice are missing their third molars, 
lack guard hairs, and have hypoplastic eccrine glands (Fig. 1, 
D–F), a phenotype observed in mice with disruption of 
the Eda gene, mutated in patients with X-linked anhidrotic 
ED (Srivastava et al., 2001).
Immunoblotting cannot distinguish between WT IB 
and the S32I mutant proteins. We sought evidence for the ex-
pression of the mutant protein in heterozygous IB mutant 
mice by examining the susceptibility of IB to phosphory-
lation and degradation after stimulation of fibroblasts with 
IL-1. IB phosphorylation was significantly weaker in fi-
broblasts from mutant mice compared with WT littermates 
(Fig. 1 G). IB was mostly degraded by 15 min and com-
pletely degraded by 30 min in WT fibroblasts. In contrast, 
there was markedly less IB degradation in the mutant fibro-
blasts. Similar results were obtained when the fibroblasts were 
stimulated with TNF and LPS, two other well-known activa-
tors of the canonical NF-B pathway (not depicted).
BMDCs were differentiated from BM cells with GM-CSF 
and IL-4 and used to examine the response to TLR ligation in 
a homogeneous population of cells. BMDCs from IB mu-
tant mice secreted significantly less TNF in response to TLR1/2, 
TLR4, TLR7, and TLR9 ligands (Fig. 1 H). Furthermore, up-
regulation of Vcam1 (Vascular adhesion molecule 1) and Icam1 
(Intercellular adhesion molecule 1) gene expression and of VCAM1 
surface expression after TNF stimulation, which are dependent 
on canonical NF-B signaling (Dejardin et al., 2002; Winning 
et al., 2010), was deficient in MEFs from IB mutant mice 
(Fig. 1, I and J). Collectively, these results indicate that the IB 
mutant mice we generated represent a faithful model of ED-ID 
caused by heterozygous IB S32I mutation.
Defective secondary lymphoid organogenesis  
in IB mutant mice
The gross appearance, weight, and cellularity of the thymus 
and the distribution of thymocyte subsets into CD4CD8 
double-negative cells, CD4+CD8+ double-positive cells, and 
CD4+ or CD8+ single-positive cells were comparable in 
IB mutant mice and WT littermates (not depicted). BM 
cellularity and distribution of (B220+IgMCD43+) pro-B, 
(B220+IgMCD43) pre-B, (B220+IgM+) immature, and 
polyubiquitination and proteasome processing into p52, al-
lowing the p52:RelB dimer to translocate into the nucleus 
and activate the transcription of genes involved in lymphoid 
organogenesis (Dejardin et al., 2002; Seymour et al., 2006). 
There is cross talk between the canonical and noncanonical 
NF-B pathways. NIK-dependent activation of IKK can 
cause IB phosphorylation and degradation, p50:p65 regu-
lates the expression of p100 and RelB, and p100 regulates 
RelA/p65-containing complexes (Matsushima et al., 2001; 
Tucker et al., 2007; Shih et al., 2011; Chen et al., 2013).
Ectodermal dysplasia with immunodeficiency (ED-ID) is 
characterized by sparse hair, conical teeth, reduced number 
of sweat glands, and susceptibility to severe infections (Kere 
et al., 1996; Srivastava et al., 2001; Orange and Geha, 2003; 
Picard et al., 2011). The X-linked form of ED-ID is caused by 
hypomorphic mutations in NEMO (Puel et al., 2004; Hanson 
et al., 2008). Autosomal-dominant (AD) ED-ID is caused by 
heterozygous hypermorphic mutations in the IB gene 
NFKBIA (Courtois et al., 2003; Kawai et al., 2012). Six muta-
tions in IB, S32I, W11X, E14X, Q9X, M37K, and S36Y, 
have been identified in AD ED-ID (Courtois et al., 2003; 
Janssen et al., 2004; McDonald et al., 2007; Lopez-Granados 
et al., 2008; Ohnishi et al., 2012; Schimke et al., 2013; Yoshioka 
et al., 2013). In each case, the mutation impairs phosphorylation-
driven degradation of the mutant protein, resulting in the 
sequestration of NF-B in the cytoplasm (Courtois et al., 
2003; McDonald et al., 2007; Kawai et al., 2012). In both 
forms of ED-ID, activation of the canonical NF-B pathway 
is impaired, resulting in ED caused by defective signaling 
downstream of the EDA receptor, impaired TLR responses, 
and decreased in vitro B cell response to CD40 ligation (Orange 
et al., 2005). The severity of the disease correlates with the 
degree of NF-B impairment (Orange and Geha, 2003).
Two aspects of the disease phenotype of patients affected 
by IB deficiency have long been a puzzle. The patients suffer 
from severe, recurrent, and potentially fatal infections despite 
having normal or elevated T and B cell numbers and intact 
in vitro T cell function (Courtois et al., 2003; Janssen et al., 2004; 
McDonald et al., 2007; Kawai et al., 2012). The outcome of 
hematopoietic stem cell transplantation (HSCT) in these pa-
tients is poor in spite of good engraftment of donor lymphoid 
cells. Of three patients treated with HSCT, only one with the 
S32I IB mutation has survived, but continues to suffer 
from recurrent infections despite excellent donor lymphoid 
cell engraftment (Dupuis-Girod et al., 2006; Cancrini, C., 
personal communication). We have created an IB S32I 
knock-in mouse model of AD ED-ID to gain insights into 
the disease. The IB mutant mouse recapitulates many of the 
ectodermal and immune abnormalities found in patients with 
ED-ID. Strikingly, the mutant completely lacked LNs and 
Peyer’s patches (PPs), and its spleen lacked follicles, marginal 
zones (MZs), MZ B cells, and follicular DCs (FDCs) and 
failed to form germinal centers (GCs), all features not previ-
ously recognized in patients with ED-ID and typical of de-
fective noncanonical NF-B signaling. The levels of p100 and 
noncanonical NF-B signaling in response to LTR ligation 
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Figure 1. IB mutant mice have ED, impaired IB processing, and deficient TLR response. (A) IB mutant mouse and WT littermate 
photographed at 3 wk of age. Data are representative of >20 mice per group. (B and C) Growth (B) and Kaplan-Meier survival (C) curves of IB 
mutant mice and WT littermates weighed every 3–4 d and observed daily. Data were derived from 34 mutant mice and 19 WT littermates weighed. 
(D–F) Photographs of mandibular bones (D) and fur (E) and H&E staining of footpad sections (F) in 6 wk-old IB mutant mouse and WT litter-
mate. Red arrows in D show the missing third molars in the mutant mice. Data are representative of four or more mice per group in three inde-
pendent experiments. Bar, 100 µm. (G) Immunoblot of fibroblast lysates using antibodies to phospho-IB or IB. Actin was used as a loading 
control. Pooled results of IB phosphorylation at 5 min using three mice per group in three independent experiments. (H) TNF as measured by 
ELISA in supernatants of BMDCs stimulated with the TLR ligands PamCsk4 (TLR1/2), LPS (TLR4), loxoribine (TLR7), and CpG oligonucleotide (TLR9). 
Data are representative of four mice per group in two independent experiments for PamCsk4 and LPS and four mice per group in three indepen-
dent experiments for loxoribine and CpG. (I and J) qPCR analysis of Vcam1 and Icam1 mRNA (I) and flow cytometric analysis of VCAM1 surface 
expression (J) after TNF stimulation in MEFs from IB mutant mice and WT controls. Results in I are expressed relative to unstimulated WT MEFs. 
Data are representative of three mice per group in three independent experiments. Circles and columns represent means, and bars represent SD in 
B, C, and G–I. *, P < 0.05; **, P < 0.01; ***, P < 0.001.
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not rule out a defect in development of MZ cells. IB mutant 
mice had increased numbers of CD11b+F4/80+ macrophages 
but normal numbers of CD11b+Ly6G+ granulocytes and 
CD3NK1.1+ cells and CD11c+ DCs compared with WT litter-
mates (not depicted). The percentages of CD11c+MHCII+B220+ 
plasmacytoid DCs and CD11c+MHCII+CD11b+CD4+ and 
CD11c+MHCII+CD11b+CD8CD4 myeloid DCs were 
comparable between the two groups, whereas the percentage of 
CD11c+MHCII+CD11bCD8+ lymphoid DCs was signifi-
cantly reduced in the mutant (9.3 ± 0.9% in the mutant vs. 
14.8 ± 1.0% in WT littermates; n = 3; P < 0.05).
IB mutant mice had a severely disorganized splenic 
architecture. H&E staining revealed virtual absence of fol-
licles (Fig. 3 G). Immunofluorescence analysis revealed that 
MOMA+ macrophages were present in IB mutant mice 
but failed to form the ring structure typical of a MZ (Fig. 3 H). 
The number of Madcam1+ cells, which represent the endo-
thelial cells that line the marginal sinus, was decreased, and the 
organization of these cells was disrupted in the IB mutant 
(Fig. 3 I). FDCM1+ FDCs were absent from the spleens of the 
mutant (Fig. 3 J).
Normal number of lymphoid tissue inducer (LTi) cells  
but defective response to LTR ligation and TNF  
in the IB mutant
Lymphorganogenesis is initiated in the embryo by the inter-
action of LTi cells with stromal organizer cells, which express 
LTR (Rennert et al., 1996; Mebius, 2003; Bénézech et al., 
2010). FACS analysis of intestine from embryonic day (E) 17 
embryos revealed the presence of higher percentages and 
numbers of CD45+CD3CD4+IL-7R+ LTi cells in IB 
mutant mice compared with WT littermates (Fig. 4, A and B), 
indicating that the IB mutation did not interfere with the 
development of LTi cells.
LTi cells express the LTR ligand LT12, whereas stro-
mal cells express LTR. LTR signaling in stromal cells is es-
sential for lymphoid organogenesis (Fu and Chaplin, 1999). 
Both the canonical and noncanonical NF-B pathways are 
(B2202+IgM+) mature B cell subsets were comparable in IB  
mutant mice and WT littermates (not depicted).
Gross examination revealed no visible cervical, axillary, in-
guinal, or mesenteric LNs in >15 IB mutant mice examined 
(Fig. 2 A and not depicted). No LN tissue could be detected in 
hematoxylin and eosin (H&E)–stained serial sections of the 
inguinal fat pad in IB mutant mice (not depicted). To con-
firm the absence of LNs, we injected mice in the footpad 
with Evan’s blue dye. Blue-colored lymphatic vessels were 
readily apparent in both mutant and WT mice. Blue-colored 
LNs could be detected in the popliteal, inguinal, and paraaortic 
area in WT mice, but were absent in the mutants (Fig. 2 B and 
not depicted). Examination of H&E-stained sections of the 
small intestine revealed no detectable PPs in seven mutant mice 
compared with 7.1 ± 2.3 PPs in seven WT littermates exam-
ined (Fig. 2 C). However, nasal-associated lymphoid tissue 
(NALT) was present in IB mutant mice, although it was less 
abundant than in WT mice (Fig. 2 D). The numbers of circulat-
ing lymphocytes were significantly increased in the IB mu-
tant mice (Fig. 3 A), a finding also reported in patients with the 
S32I IB mutation (Courtois et al., 2003; Janssen et al., 2004) 
and in LT/, LT/, and LTR/ mice that lack both 
LNs and PPs but have detectable NALT (De Togni et al., 1994; 
Ware et al., 1995; Alimzhanov et al., 1997; Matsumoto et al., 
1997; Fütterer et al., 1998; Tumanov et al., 2003).
The cellularity of the spleen was greater in IB mutant 
mice than WT littermates, but the difference was not statisti-
cally significant (Fig. 3 B). The number of splenic T cells and 
the distribution of CD4+ and CD8+ subsets were comparable 
between the IB mutant mice and WT littermates (Fig. 3 C). 
Analysis of B cell subsets revealed comparable percentages of 
B220+CD93+ transitional B cells and B220+CD23+CD21 
follicular cells in the two groups but drastically reduced 
percentages of B220+CD23CD21+ MZ B cells in mutant 
spleens (Fig. 3, D and F). The percentages of MZ B cells in the 
blood were comparable in the mutant and WT littermates 
(12.1 ± 1.0% in the mutant vs. 10.6 ± 1.8% in WT litter-
mates; n = 3). Given the severe decrease in splenic MZ B cells 
in the mutant, this result suggests a retention defect but does 
Figure 2. IB mutant mice lack LNs and PPs. (A and B) Photograph of mesenteric area (A) and popliteal LNs (B) in an IB mutant mouse and WT 
littermate. Mice in B were injected with Evan’s blue. The normal position of LNs is outlined by a dotted circle. Arrows indicate the lymphatic vessels. 
(C and D) Longitudinal sections of the small intestine (C) and transverse sections of the head at the level of the nasal cavities (D) were stained with H&E. 
Bars, 1,000 µm. Data in A–D are representative of a minimum of three mice per group in three independent experiments.
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these mice. We stimulated MEFs, as surrogates for stromal 
cells, with the agonistic LTR mAb AFH6 and examined 
the induction of Vcam1 and Icam1 expression, as readouts of 
canonical NF-B activation (Dejardin et al., 2002), Cxcl10 
(C-X-C motif chemokine 10) expression, as a readout of pre-
dominantly canonical NF-B activation (Hoffmann et al., 
2003; Caposio et al., 2007; Shultz et al., 2009), and Madcam1 
activated by LTR and are important for the expression of 
adhesion molecules and chemokines that drive lymphoid or-
ganogenesis, with the noncanonical pathway playing a major 
role (Miyawaki et al., 1994; Koike et al., 1996; Shinkura et al., 
1999; Dejardin et al., 2002; Lo et al., 2006; Vondenhoff et al., 
2009). The absence of secondary lymphoid structures in IB 
mutant mice prompted us to examine LTR signaling in 
Figure 3. IB mutant mice lack splenic follicles, MZs, MZ B cells, and FDCs. (A) Blood lymphocyte numbers in IB mutant mice and WT litter-
mates evaluated by CBC analysis using HEMAVET 950FS. Data are representative of three mice per group in two independent experiments. (B–D) Numbers 
of total splenocytes (B), CD3+, CD4+, and CD8+ T cells (C), and B220+ B cells (D) in IB mutant mice and WT littermates calculated by multiplying the 
spleen cell counts evaluated in a hemocytometer by the percentage of lymphocytes and those of CD3+, CD4+, and CD8+ T cells and of B220+ obtained by 
flow cytometry. Data are representative of three to eight mice per group in three independent experiments. (E and F) Distribution of CD93+ transitional 
(Trans) B cells, CD21CD23+ follicular (FO) B cells, and CD21+CD23 MZ B cells in gated B220+ splenic B cells (E) and percentages of these cells among 
splenic B220+ cells (F) in IB mutant mice and WT littermates analyzed by flow cytometry. Data are representative of three to six mice per group in 
three independent experiments. (G–J) Sections of naive spleens stained with H&E (G) and the presence of cell staining for MOMA, IgM, and IgD (H),  
Madcam1 and CD4 (I), and FDCM1 and B220 (J) as determined by immunofluorescence. Bars: (G) 500 µm; (H–J) 100 µm. Data in G–J is representative  
of a minimum of four mice per group in three independent experiments. Columns and bars represent mean and SD. **, P < 0.01; ***, P < 0.001.
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reduced in spleens of IB mutant mice compared with WT 
littermates (Fig. 4 D).
Expression in cell lines of the genes that encode for the 
noncanonical NF-B family members p100 and RelB have 
been reported to be regulated by the canonical NF-B 
pathway (Liptay et al., 1994; Bren et al., 2001). The level of 
p100, but not RelB, was significantly reduced in B cells 
from IB mutant mice (Fig. 4, E and F). NIK levels were 
comparable in B cells from IB mutant mice and WT 
controls (not depicted). These findings suggest that the 
S32I IB mutation impairs signaling via the noncanoni-
cal NF-B pathway because it results in diminished ex-
pression of p100.
expression, as a readout of noncanonical NF-B pathway 
activation downstream of LTR (Ganeff et al., 2011). Expres-
sion of all these genes after stimulation with LTR mAb AFH6 
was significantly reduced in MEFs from IB mutant mice 
compared with WT controls (Fig. 4 C and not depicted).
Induction of the chemokine genes Ccl19 (C-C motif che-
mokine 19), Cxcl12, and Cxcl13 after LTR signaling is im-
portant for lymphoid organogenesis and is dependent on the 
noncanonical NF-B pathway (van de Pavert et al., 2009; 
van de Pavert and Mebius, 2010). Because LTR failed to 
up-regulate the expression of these genes in WT MEFs (not 
depicted), we examined their baseline expression in the spleen. 
Expression of all three chemokine genes was significantly 
Figure 4. Defective response to LTR 
ligation and decreased p100 levels in the 
IB mutant. (A) CD4+IL-7R+ LTi cells in 
CD45+CD3 gated intestinal cells of E17 em-
bryos analyzed by flow cytometry. (B) Per-
centage of LTi cells among CD45+CD3 cells 
analyzed by flow cytometry and numbers of 
LTi cells in E17 intestinal cells calculated from 
the numbers of CD45+CD3 cells and per-
centage of LTi cells. Data in A and B are repre-
sentative of five mice per group. (C) Vcam1, 
Icam1, Cxcl10, and Madcam1 mRNA expres-
sion in MEFs stimulated with the LTR mAb 
AHF6 and analyzed by qPCR. Results are ex-
pressed as fold increase relative to unstimu-
lated WT controls. Data are representative of 
three mice per group in three experiments. 
(D) Cxcl12, Cxcl13, and Ccl19 mRNA expres-
sion in the spleen of IB mutant and WT 
littermates analyzed by qPCR. Results are 
expressed as fold increase relative to WT con-
trols. Data are representative of four mice per 
group in two experiments. (E and F) Represen-
tative immunoblot analysis of p100 (E) and 
RelB (F) in lysates of purified splenic B cells 
with actin as control (top) and p100 (E) and 
RelB (F) expression in B cells from the IB 
mutant relative to WT (bottom) calculated at 
the ratio of p100 and RelB to actin in lysates 
of B cells from the IB mutant relative to 
that in lysates of WT B cells. Data are repre-
sentative of three to seven mice per group in 
three experiments. Columns and lines repre-
sent means, and bars represent SD in B–F.  
*, P < 0.05; **, P < 0.01; ***, P < 0.001.
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in response to immobilized anti-CD3 were comparable in 
mutant mice and WT littermates (Fig. 5, A and B). CD28 li-
gation increased IL-2 secretion by the mutant T cells, albeit 
to a significantly lower extent than in WT T cells (Fig. 5 B). 
Normal intrinsic T cell function but impaired delayed 
contact hypersensitivity (CHS) in IB mutant mice
T cell proliferation upon stimulation with immobilized anti-
CD3 with and without soluble anti-CD28 and IL-2 secretion 
Figure 5. Normal intrinsic T cell function but impaired CHS in IB mutant mice. (A and B) Proliferation determined by [3H]thymidine incorpora-
tion into DNA (A) and IL-2 secretion determined by ELISA of supernatants (B) by purified splenic T cells stimulated for 3 (A) or 2 (B) d with immobilized 
anti-CD3 mAb (A) or immobilized anti-CD3 + soluble anti-CD28 mAb (B). Data represent a minimum of five mice per group in A and four in B in three 
independent experiments. (C) Cytokine secretion determined by ELISA on supernatants of purified splenic T cells stimulated with immobilized anti-CD3 
mAb + anti-CD28 mAbs in the absence of added cytokines (Th0 condition) or in Th2, Th1, or Th17 polarizing conditions. Data represent five mice per 
group in three independent experiments. (D) Proliferation determined by [3H]thymidine incorporation into DNA and IL-2 production determined by ELISA 
of supernatants by splenocytes from i.p. immunized mice stimulated with OVA for 3 d for proliferation and 2 d for Il-2 production. Data represent five 
mice per group in three independent experiments. (E–G) H&E-stained sections of the ears (E), increase in ear thickness measured by a micrometer (F), and 
Ifng and Il-4 mRNA expression determined by qPCR (G) 24 h after ear challenge with OXA or vehicle. Results in F are represented as the fold increase 
relative to vehicle-challenged ears of WT controls. Bar, 200 µm. Data in E–G represent five to seven mice per group in three independent experiments. 
Columns and bars in A–D, F, and G represent mean and SD. *, P < 0.05; **, P < 0.01; ***, P < 0.001.
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indicate that TCR-driven T cell proliferation, IL-2 secre-
tion, and in vitro Th2 cell differentiation were normal in the 
mutant, but in vitro Th1 and Th17 cell differentiation were 
significantly impaired.
The differentiation of naive CD4+ T cells in vitro under po-
larizing conditions into Th2 cells was comparable in the mu-
tant and WT littermates, but differentiation into Th1 and Th17 
cells was impaired in the mutant (Fig. 5 C). These findings 
Figure 6. B cell function in IB mutant mice. (A and B) Proliferation determined by [3H]thymidine incorporation into DNA (A) and IgM and IgG 
production determined by ELISA in the supernatants (B) of purified splenic B cells stimulated for 3 d with LPS. Data are representative of a minimum of 
four mice per group in three experiments. (C) Aicda and Prdm1 mRNA expression in B cells stimulated with 10 µg/ml LPS measured by qPCR. Data are 
representative of three mice per group in three experiments. (D) Proliferation by purified splenic B cells stimulated with anti-, anti-CD40 mAb, LPS, or 
TGF in the presence of IL-4 determined by [3H]thymidine incorporation into DNA. Data are representative of a minimum of four mice per group in three 
experiments. (E) IgA production by purified splenic B cells stimulated with LPS + TGF, as determined by ELISA of supernatants. Data are representative of 
a minimum of four mice per group in four experiments. (F and G) B cell survival mediated by BAFF determined by analysis of trypan blue–negative cells (F) 
and IgG1 production determined by ELISA in the supernatants (G) by purified naive splenic B cells stimulated with BAFF in the absence or presence of IL-4 
for 4 (F) or 7 (G) d. Data are representative of three mice per group in three experiments. (H) Serum Ig levels from unimmunized 6–8-wk-old mice. Data 
represent the mean of duplicate determinations on sera from the number of mice indicated. (I) Small intestine sections were stained by immunofluor-
escence for IgA, CD45, and DAPI. The dashed line delineates the edge of the PP. Bars, 100 µm. Data are representative of two independent experiments 
with one mouse per group. Lines and columns represent mean, and bars represent SD. *, P < 0.05; **, P < 0.01; ***, P < 0.001.
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response to TD antigens requires GC formation (Rajewsky, 
1996). OVA immunization resulted in the robust development 
of GCs in the spleens of WT mice as indicated by staining for 
peanut agglutinin (PNA; Fig. 7 D). In contrast, GC develop-
ment was severely deficient in IB mutant mice. OVA im-
munization caused a significant increase in the percentage of 
B220+PNA+ and B220+Fas+GL7+ GC B cells in the spleens of 
WT mice but not IB mutant mice (Fig. 7, E and F).
Reconstitution of IB mutant mice with WT BM fails to 
correct their secondary lymphoid organs and immune defects
To determine whether the immune phenotype of IB mu-
tant mice was intrinsic to lymphocytes, we examined immune 
function in WT→IB mutant chimeras. The same pool 
of BM cells from CD45.1+ WT mice was used to reconstitute 
irradiated CD45.2+ IB mutant mice and WT littermates. 
8 wk after BM transplantation, the two chimeras had compa-
rable numbers of lymphocytes in the blood, with virtually all 
B cells and >80% of T cells of donor origin (not depicted). 
Gross examination revealed that LNs and PPs were present in 
WT→WT control chimeras (Fig. 8, A and B). In contrast, 
they were not detectable in WT→IB mutant chimeras. 
Splenic cellularity and the percentages of CD3+, CD4+, 
CD8+, and B220+ cells were comparable in the two chimeras 
(not depicted). However, follicles and FDCs, which were 
present in the spleens of control chimeras, were absent from 
WT→IB mutant chimeras (Fig. 8 C), and the percentage 
of MZ B cells was distinctly decreased in the WT→IB 
mutant chimeras (Fig. 8 D). These findings strongly suggest 
that nontransferable stromal cells are responsible for the lack 
of LNs, PPs, splenic follicles, and FDCs and for the decrease 
in MZ B cells in IB mutant mice.
Evaluation of CHS revealed significantly decreased ear 
swelling, inflammation, and cytokine expression in WT→
IB mutant chimeras compared with control chimeras 
(Fig. 8, E–G). WT→IB mutant chimeras had impaired 
antibody responses to TNP-Ficoll and OVA compared with 
control chimeras (Fig. 8, H and I). OVA immunization re-
sulted in the development of GCs and in a significant increase 
in the percentage of B220+PNA+ GC B cells in the spleens 
of control chimeras, but not WT→IB mutant chimeras 
(Fig. 8, J and K). The failure of reconstitution with WT BM 
cells to correct the immune defects in IB mutant mice in-
dicates that nonhematopoietic cells are major contributors to 
the immune deficiency in IB mutant mice.
Secondary lymphoid organs, CHS, and GC formation, but not  
B cell function, are restored in IB mutant→Rag2/ chimeras
Rag2/ mice possess LTi cells, and the cross talk between 
LTi cells and stromal cells is intact in these mice (Fu and 
Chaplin, 1999). To determine whether some of the immune 
defects in IB mutant mice are intrinsic to hematopoietic 
cells, we generated Rag2/ chimeras. LNs were present and 
comparable in size, cellularity, and distribution of T and B cells 
in IB mutant→Rag2/ chimeras and WT→Rag2/ 
control chimeras (Fig. 9, A and B). PPs and splenic follicles 
After i.p. immunization with OVA, T cells in splenocyte 
cultures from IB mutant mice proliferated normally and 
secreted IL-2 robustly in response to OVA stimulation (Fig. 5 D). 
In contrast to the response to i.p. immunization, which in-
volves interaction in the spleen between antigen-presenting 
DCs and T cells, the T cell response to cutaneously introduced 
antigen involves interaction in the skin-draining LN between 
DCs that have captured antigen in the skin and recirculating 
antigen-specific T cells. IB mutant mice sensitized with 
the hapten oxazolone (OXA) developed significantly less ear 
swelling with markedly less cellular infiltration and expressed 
significantly less Ifng and Il4 mRNA than WT controls (Fig. 5, 
E and F). Because IB mutant mice have partial intrinsic 
T cell defects, the absence of LNs likely plays a major role in 
the failure of these mice to mount a CHS response.
B cell function is modestly decreased in vitro but severely 
impaired in vivo in IB mutant mice
Proliferation and IgG secretion by purified total splenic B cells 
in response to stimulation with LPS were modestly, but 
significantly, reduced in the mutant, whereas IgM secretion 
was not significantly reduced (Fig. 6, A and B). Aicda (activa-
tion-induced cytidine deaminase) expression in LPS-stimulated 
B cells from the mutant was comparable with WT controls, 
but Prdm1 (PR domain zinc finger protein 1) expression was sig-
nificantly decreased (Fig. 6 C). The proliferation of splenic 
B cells from IB mutant mice in response to stimulation 
with anti-IgM + IL-4, anti-CD40 + IL-4, LPS + IL-4, and LPS + 
TGF was modestly, but significantly, decreased compared 
with B cells from WT littermates, as measured by [3H]thymidine 
incorporation (Fig. 6 D) and CFSE dye dilution (not de-
picted). IgM, but not IgG, production was significantly 
decreased in response to LPS + IL-4 and anti-CD40 + IL-4 
(not depicted), suggesting that IL-4 may overcome some of 
the hyporesponsiveness of the B cells to LPS alone. LPS + 
TGF stimulation caused significantly less IgA production by 
mutant B cells than by WT B cells (Fig. 6 E). BAFF, which ac-
tivates primarily the noncanonical NF-B pathway (Claudio 
et al., 2002), promotes B cell survival and drives modest IgG1 
isotype switching in naive B cells (Batten et al., 2000; Castigli 
et al., 2005). The survival of naive B cells in the presence of 
BAFF and their IgG1 production in response to BAFF alone 
or with added IL-4 were significantly reduced in IB mu-
tant mice compared with WT littermates (Fig. 6, F and G). 
This is consistent with the impaired noncanonical NF-B 
signaling in the mutant.
Serum IgM levels were comparable in mutant mice and 
WT littermates, whereas serum IgG levels were significantly 
decreased, and serum IgA was nearly absent in the mutants 
(Fig. 6 H). IgA+ plasma cells were absent from the lamina 
propria of mutant mice (Fig. 6 I).
The antibody responses to the type I T-independent (TI) 
antigen TNP-LPS, the type II TI antigen TNP-Ficoll, and the 
T-dependent (TD) antigens OVA and TNP-KLH were all se-
verely diminished in IB mutant mice compared with WT 
controls (Fig. 7, A–C; and not depicted). The IgG antibody 
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on B220+PNA+ cells revealed that mRNA levels of Aicda and 
Bcl6, which are expressed by GC B cells, were comparable in 
the two chimeras. In contrast, mRNA levels of Prdm1 and 
Xbp1 (X-box–binding protein 1), which drive plasma cell differ-
entiation, were significantly lower in the IB mutant→
Rag2/ chimeras than in control chimeras (Fig. 10 I). These 
results suggest that defective GC formation in IB mutant 
mice is caused by a defect in nonhematopoietic architectural 
cells rather than in hematopoietic cells. Nevertheless, the B cells 
from the mutant have an intrinsic defect in terminal differen-
tiation into plasma cells.
DISCUSSION
We have generated mice heterozygous for the S32I mutation 
in IB that recapitulate the known features of ED-ID patients 
who carry the same mutation. Strikingly, these mice had se-
verely defective lymphoid organogenesis caused by a defect in 
nontransferable architectural cells, a finding not previously 
appreciated in patients, which may explain their susceptibility 
to infection despite normal lymphocyte number and in vitro 
function and their poor response to HSCT.
and FDCs were also present and comparable in size in the 
two chimeras (Fig. 9, C and D). Furthermore, MZ B cells 
were present in IB mutant→Rag2/ chimeras, although 
their number was less than in control chimeras (Fig. 9 E). 
These findings indicate that the defective lymphoid organo-
genesis in IB mutant mice was not caused by an intrinsic 
defect in hematopoietic cells.
IB mutant→Rag2/ chimeras mounted a CHS re-
sponse to OXA comparable with that of control chimeras, as 
measured by ear swelling, cellular infiltration, and Ifng and Il4 
mRNA expression (Fig. 10, A–C). These findings strongly 
suggest that the lack of CHS in the IB mutants is caused 
by their lack of LNs.
Despite the presence of splenic follicles, FDCs, and MZ 
B cells, the antibody responses to TNP-LPS, TNP-Ficoll, and 
OVA were all significantly lower in IB mutant→Rag2/ 
chimeras than in control chimeras (Fig. 10, D–F). After OVA 
immunization, the chimeras formed splenic GCs that were 
comparable in size and number (Fig. 10 G) and had a com-
parable increase in the percentage of B220+PNA+ cells 
(Fig. 10 H). Quantitative PCR (qPCR) analysis performed 
Figure 7. Impaired antibody responses in IB mutant mice. (A–C) TNP-specific serum Ig measured by ELISA in mice immunized with TNP-LPS (A) 
and TNP-Ficoll (B) and OVA-specific serum Ig measured by ELISA in mice immunized with OVA (C). Data represent the mean of duplicate determinations on 
sera from four to seven mice per group. (D) Spleen sections from immunized mice were stained by histochemistry with anti-B220 or PNA. Bars, 500 µm.  
Data are representative of six mice per group in three independent experiments. (E and F) Analysis of PNA+ and Fas+GL7+ B cells among the B220+  
population of splenic B cells of OVA-immunized mutant mice and WT controls (E) and percentages of these subpopulations in unimmunized and OVA-
immunized mice of both groups (F), as analyzed by flow cytometry. Data are representative of three to six mice per group in three independent experi-
ments. Imm, immunization. Lines and columns represent mean, and bars represent SD in A–C and F. *, P < 0.05; **, P < 0.01; ***, P < 0.001.
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Figure 8. Secondary lymphoid organs and immune function in WT→IB mutant chimeras. (A) Photograph of inguinal fat pad with the vessel 
junction. The dotted circle indicates the LN at the vessel junction in the fat pad. (B) H&E staining of small intestine sections. The arrow points to a PP  
in the WT mouse. (C) Spleen sections were stained with H&E (left) and by immunofluorescence for FDCM1, IgD, and IgM (right). (D) Percentage of 
CD21+CD23 MZ B cells among B220+ cells in the spleen, as determined by flow cytometry (n = 4–6 mice per group). (E–G) Increase in ear thickness mea-
sured by a micrometer (E), representative H&E-stained sections (F), and Ifng and Il-4 mRNA expression determined by qPCR (G) 24 h after ear challenge 
with OXA or vehicle (n = 3–5 mice per group). (H and I) Serum TNP-specific (H) and OVA-specific (I) antibody measured by ELISA in mice immunized with 
TNP-Ficoll (H) and OVA (I), respectively (n = 5 mice per group). (J) Spleen sections from immunized mice stained by histochemistry with anti-B220 mAb or 
PNA. Bars: (B) 500 µm; (C [left], F, and J) 200 µm; (C, right) 100 µm. (K) Percentage of PNA+ B cells among the B220+ population of splenic B cells deter-
mined by flow cytometry (n = 3–5 mice per group). Data in A–C and J are representative of three to six mice. Columns and bars in D, E, G–I, and K repre-
sent mean and SD. *, P < 0.05; **, P < 0.01; ***, P < 0.001.
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Kim et al., 2000). Instead, the phenotype of IB mutant mice 
closely resembles that of mice deficient in RelB or NIK and 
mice deficient in LT, LT, or LTR, which signal through 
both the canonical and noncanonical NF-B pathways 
(Miyawaki et al., 1994; Banks et al., 1995; Weih et al., 1995; Koike 
et al., 1996; Koni et al., 1997; Fütterer et al., 1998; Weih et al., 
2001; Tumanov et al., 2003; Seymour et al., 2006).
Defective lymphoid organogenesis has not been previ-
ously appreciated in patients with ED-ID. However, tonsils 
and cervical LNs have been noted to be absent in at least one 
of the patients with the S32I IB mutation (Dupuis-Girod 
et al., 2006). Circulating lymphocyte counts were signifi-
cantly elevated in IB mutant mice, as has been noted in 
patients with IB deficiency (Courtois et al., 2003; Janssen 
et al., 2004; McDonald et al., 2007; Ohnishi et al., 2012) and 
in mice that lack LNs and PPs (De Togni et al., 1994; 
Alimzhanov et al., 1997; Fütterer et al., 1998).
Lymphoid organogenesis involves activation of both the 
canonical and noncanonical NF-B pathways through LT12-
LTR interactions between LTi cells and stromal organizer cells 
(Mebius, 2003; Vondenhoff et al., 2009; van de Pavert and 
Mebius, 2010; Roozendaal and Mebius, 2011). LTi cells were 
present in the IB mutant, consistent with previous observations 
in mice with defects in the canonical NF-B pathway (Alcamo 
et al., 2002). As expected, MEFs from the mutant failed to up-
regulate Vcam1, Icam1, and Cxcl10 mRNA expression in response 
to LTR ligation, which depends on the canonical NF-B 
pathway (Dejardin et al., 2002; Caposio et al., 2007). In addi-
tion, they failed to up-regulate the expression of Madcam1, 
which depends on the noncanonical pathway downstream of 
The IB mutant mouse we generated had ectodermal 
defects similar to those present in EDA- and EDA-R–deficient 
patients and mice and in patients with ED-ID (Srivastava et al., 
2001; Laurikkala et al., 2002; Clauss et al., 2008; Hanson et al., 
2008; Kawai et al., 2012). Growth, weight gain, and survival 
were diminished in the mutant, like in patients with hyper-
morphic IB mutations (Courtois et al., 2003; Janssen et al., 
2004; McDonald et al., 2007; Lopez-Granados et al., 2008; 
Ohnishi et al., 2012; Yoshioka et al., 2013). Activation of the 
canonical NF-B pathway was deficient in these mice, as 
in the patients (Courtois et al., 2003; McDonald et al., 2007). 
This was indicated by impaired IB phosphorylation and 
degradation in fibroblasts after stimulation with IL-1, TNF, 
and LPS. The mutant also showed reduced cytokine produc-
tion by BMDCs in response to TLR stimulation and decreased 
up-regulation of ICAM1 and VCAM1 expression by MEFs in 
response to TNF. Thus, the heterozygous IB mutant mice 
we generated represent a faithful model of humans with hyper-
morphic IB mutations.
Secondary lymphoid organogenesis was severely defective 
in the IB mutant mouse. The mutant completely lacked 
LNs and PPs, and its spleen lacked follicles, MZs, MZ B cells, 
and FDCs. This was surprising because secondary lymphoid 
organogenesis is relatively well preserved in p50-deficient 
mice, which only lack inguinal LNs (Lo et al., 2006), and par-
tially preserved in mice deficient in TNF, TNFR1 (TNF re-
ceptor 1), RANK (receptor activator of NF-B), or RANKL 
(RANK ligand), which signal through the canonical NF-B 
pathway (Pasparakis et al., 1996, 1997; Körner et al., 1997; 
Matsumoto et al., 1997; Dougall et al., 1999; Kong et al., 1999; 
Figure 9. Defective lymphoid organogenesis in IB 
mutant→Rag2/ chimeras. (A) Inguinal LN sections 
stained with H&E. (B) Numbers of total cells and B and  
T cells from inguinal and axillary LNs (one from each mouse) 
evaluated by counting in a hemocytometer. (C) H&E staining 
of longitudinal sections of the small intestine. (D) Spleen 
sections were stained with H&E (left) and by immunofluor-
escence for B220 and FDCM1 (right). Bars: (A and D [right]) 
100 µm; (C) 1,000 µm; (D, left) 200 µm. (E) Percentage of 
CD21+CD23 MZ B cells among the B220+ cells in the spleen 
determined by flow cytometry. Data in A–E are representa-
tive of four to six mice per group in three to four indepen-
dent experiments. Columns and bars in B and E represent 
mean and SD. **, P < 0.01.
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for p100 processing into its active product p52 (Dejardin et al., 
2002), the impaired noncanonical NF-B pathway activity in 
the mutant is likely caused by the decreased p100 levels.
In addition to the control of p100 level by the canonical 
pathway, there is cross talk at other levels between the 
canonical and noncanonical NF-B pathways (Matsushima 
et al., 2001; Shih et al., 2011). The complexity of this talk may 
account for the variable effects of deficiency in individual 
components of the canonical NF-B pathway on lymphoid 
LTR (Ganeff et al., 2011). Furthermore, splenocytes from the 
IB mutant expressed significantly less mRNA for the chemo-
kine genes Ccl19, Cxcl12, and Cxcl13, the expression of which 
depends on the noncanonical NF-B pathway (Dejardin et al., 
2002). We demonstrated that the levels of p100 were markedly 
reduced in cells from the mutant. This is consistent with previ-
ous observations that canonical NF-B signaling controls p100 
levels in cell lines (Liptay et al., 1994; Dejardin et al., 2002; Shih 
et al., 2011). Because canonical NF-B activation is not required 
Figure 10. Defective immune function in IB mutant→Rag2/ chimeras. (A–C) Increase in ear thickness measured by a micrometer (A), repre-
sentative H&E-stained sections (B), and Ifng and Il-4 mRNA expression determined by qPCR (C) 24 h after ear challenge with OXA or vehicle. Data in A–C 
are representative of five to seven mice per group in three experiments. (D–F) Serum TNP-specific (D and E) and OVA-specific (F) antibody measured by 
ELISA in mice immunized with TNP-LPS (D), TNP-Ficoll (E), and OVA (F), respectively. Data in D–F are representative of a mean of two determinations on 
sera from 5–10 mice per group. (G) Spleen sections from immunized mice stained by histochemistry with anti-B220 or PNA. Bars: (B) 200 µm; (G) 25 µm. 
(H) Percentage of PNA+ B cells among the B220+ population of splenic B cells (n = 3 mice per group) determined by flow cytometry. (I) Aicda, Bcl6, Prdm1, 
and Xbp1 mRNA expression in B220+PNA+ cells from immunized mice measured by qPCR. Data in G–I are representative of three mice per group in three 
experiments. Columns and bars in A, C–F, H, and I represent mean and SD. *, P < 0.05; **, P < 0.01; ***, P < 0.001.
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(Balázs et al., 2002; Pillai et al., 2005). Remarkably, despite in-
tact proliferation of splenic T cells in response to OVA stimu-
lation ex vivo, the antibody response of the mutant to i.p. 
immunization with OVA was virtually absent and was accom-
panied by a total failure to form GCs. None of the antibody 
responses were restored in IB mutant→Rag2/ chimeras, 
despite the restoration of MZ B cells and GC formation with 
generation of normal numbers of PNA+ B cells, suggesting that 
an intrinsic defect in terminal B cell differentiation exits in the 
mutant. This was supported by the observation that the ex-
pression by PNA+ cells of Prdm1 and Xbp1, which encode two 
transcription factors required for plasma cell differentiation, 
was significantly reduced in the IB mutant→Rag2/ chi-
meras. Thus, the defective antibody response of IB mutant 
mice is two-tiered, involving defective lymphoid organogene-
sis and an intrinsic defect in terminal B cell differentiation.
Reconstitution of the IB mutant with WT BM cells 
failed to restore lymphoid organogenesis and to correct the 
immune defects in irradiated IB mutant recipients, despite 
excellent chimerism in the T and B cell lineages. This finding 
recapitulates the poor results of allogeneic HSCT in patients 
with IB mutations despite the engraftment of donor lym-
phocytes. Notably, despite 100% chimerism in lymphoid 
cells, the single patient with the S32I IB mutation who has 
survived HSCT continues to suffer from recurrent infections 
requiring gamma globulin replacement and has persistent 
lymphocytosis, no visible tonsillar tissue, and no palpable LNs 
even during infection (Dupuis-Girod et al., 2006; Cancrini, 
C., personal communication).
Our findings suggest that defects in architectural nonhema-
topoietic cells, likely a mesenchymally derived stromal cell, un-
derlie the immune deficiency in patients with ED-ID caused by 
mutations in IB and explain the poor outcome of allogeneic 
HSCT in these patients. Strategies that correct defective archi-
tectural cell function, such as implantation of stromal cell– 
embedded biocompatible scaffolds to generate LNs (Okamoto 
et al., 2007), may be valuable in patients with IB deficiency.
MATERIALS AND METHODS
Generation of heterozygous IB S32I knock-in mice. The arms of the 
IB S32I targeting vector were amplified by PCR from genomic DNA of 
the CJ7 embryonic stem (ES) cell line derived from the 129Sv mouse strain. 
The 2.8-kb 5 and 3.1-kb 3 arms were cloned into the pKS-neo-DTAIII 
vector (a gift from the laboratory of M. Greenberg, Harvard Medical School, 
Boston, MA), and the nucleic acid G94T mutation was introduced by site- 
directed mutagenesis (Agilent Technologies) into exon 1 in the 5 arm, resulting 
in the amino acid S32I mutation (Fig. S1 A). The linearized targeting construct 
was electroporated into CJ7 ES cells, which were then selected in 0.4 mg/ml 
G418 and 10 mg/ml ganciclovir. An ES cell clone containing a disrupted allele 
and no random integration of the neomycin-resistance gene was confirmed by 
PCR and Southern blotting (Fig. S1 B) and then injected into 3.5-d-old 
C57BL/6 blastocysts, and IB S32I heterozygous neo mice were obtained 
by standard methods (Tsitsikov et al., 1997). The presence of mutant RNA 
was confirmed by amplifying cDNA with the primers 5-CAGGACTGGGC-
CATGGAG-3 and 5-ATCTCCCGCAGCTCCTTC-3, followed by di-
gestion with the restriction enzyme MwoI (Fig. S1 C).
Mice were backcrossed nine generations to C57BL/6 mice from Charles 
River. All mice were kept in a specific pathogen–free environment in autoclaved 
organogenesis. Thus, although lymphoid organogenesis is 
absent in Rela/ mice rescued from lethality by breeding on 
the Tnfr1/ background (Alcamo et al., 2002), it is rela-
tively unaffected in p50-deficient Nfkb1/ mice. NEMO- 
deficient patients are known to possess LNs (Orange et al., 2004; 
Imamura et al., 2011). A recent study demonstrates increased 
baseline levels of NIK and increased activation of the nonca-
nonical pathway in NEMO-deficient MEFs caused by loss of 
the IKK complex (Gray et al., 2014). Although not discussed 
in that study, p100 levels were low in these MEFs. Increased 
NIK levels and activity in NEMO deficiency may compen-
sate for the low levels of p100. In contrast, NIK levels were 
not increased in MEFs from the IB mutant mice.
Thymocyte development and splenic T cell numbers 
were normal in the IB mutant. Moreover, T cell prolifera-
tion and IL-2 secretion in response to TCR ligation with 
anti-CD3 or antigen stimulation after i.p. immunization were 
normal in the mutant. However, up-regulation of IL-2 secre-
tion by CD28 ligation and in vitro differentiation of naive 
T cells into Th1 and Th17, but not Th2 cells, were impaired. 
The CHS response, which largely depends on T cells (Wang 
et al., 2000; Gorbachev and Fairchild, 2004), was markedly 
deficient in the mutant. Failure to mount a CHS response 
also occurs in Ltbr/ mice (Rennert et al., 2001) and is likely 
caused by the absence of LNs, where contact between 
hapten-specific T cells and hapten-bearing DCs takes place. This 
is supported by the observation that the CHS response was 
reconstituted in IB mutant→Rag2/ chimeras, which 
developed LNs that were normal in size and cellularity.
The IB mutant had normal B cell development in the 
BM and normal B cell numbers in the spleen, but had a severe 
deficiency in splenic MZ B cells. Proliferation of mutant B cells 
to LPS was normal, but proliferation to response to BCR, 
CD40, and TLR4 ligation in the presence of IL-4 was modestly 
reduced, suggesting a role for IB in B cell proliferation sup-
ported by IL-4. B cells from the mutant secreted less IgG after 
LPS stimulation and less IgA after LPS + TGF stimulation than 
control B cells. Expression of Aicda was normal, but expression 
of Prdm1 was reduced in LPS-stimulated B cells from the mu-
tant, suggesting a defect in terminal B cell differentiation. B cell 
survival and IgG1 isotype switching in response to BAFF, which 
activates NF-B primarily via the canonical pathway, was im-
paired in the mutant. Serum IgG levels were decreased in the 
mutant mice, and serum IgA and intestinal IgA+ cells were virtu-
ally undetectable. IgA levels are low in patients with the IB 
S32I mutation (Courtois et al., 2003; Janssen et al., 2004). Serum 
IgA is virtually absent in Ltbr/ and NIK-deficient mice 
(Shinkura et al., 1999), and its level is decreased in Nfkb1/ 
mice (Snapper et al., 1996) and Rela//Tnfr1/ mice, which 
have impaired canonical signaling (Alcamo et al., 2002). Thus, 
defects in both canonical and noncanonical pathways may un-
derline the absence of IgA in the mutant.
Antibody responses to TI and TD antigens were severely 
deficient in the mutant. The defective response to TNP-Ficoll 
is consistent with the virtual absence of MZ B cells, which play 
a critical role in the antibody response to type II TI antigens 
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qPCR. MEFs were stimulated with 2 µg/ml anti-LTR agonist antibody 
AFH6 (a gift from J. Browning, Biogen Idec, Cambridge, MA) or 10 ng/ml 
TNF (R&D Systems) for 24 h, and RNA was extracted using the TRIzol 
(Invitrogen) method. cDNA was synthesized using iScript (Bio-Rad Labo-
ratories), and qPCR was performed using TaqMan probes and the 7300 
Real-time PCR System (Applied Biosystems).
Purification and stimulation of splenic T and B cells. T cells were puri-
fied from spleen suspensions using the pan-T cell isolation kit II (Miltenyi 
Biotec), and 100,000 per 96 wells were plated, along with 300,000 irradiated 
(3,000 rad) non-T cell APCs purified by the CD90.2 kit (Miltenyi Biotec) 
using RPMI supplemented with penicillin/streptomycin, Hepes (Gibco), so-
dium pyruvate, and -mercaptoethanol (Sigma-Aldrich). Plates were coated 
with 0.25–4 µg/ml anti-CD3 (clone 145-2C11; eBioscience) at 37°C for 1 h 
and washed with PBS, and cells were then cultured with or without the addi-
tion of 1 µg/ml anti-CD28 (clone 37.51; eBioscience). Cells were also stimu-
lated with 200 µg/ml OVA (Sigma-Aldrich). Tritiated thymidine was added 
on day 3, and incorporation was assayed after 15–18 h. IL-2 production was 
assayed from day 2 supernatants by ELISA (eBioscience).
Assays for B cell proliferation, Ig production, and GC formation were 
performed as previously described (Koduru et al., 2010). In brief, B cells 
were purified from spleen suspensions using anti-CD43 microbeads (Mil-
tenyi Biotec), resuspended in RPMI supplemented with penicillin/strepto-
mycin, Hepes, sodium pyruvate, and -mercaptoethanol. 200,000 cells in 
96-well plates were plated for proliferation assays, and 250,000 per 24-well 
plates for in vitro Ig analysis. Cells were stimulated with 0.1–10 µg/ml LPS 
(Sigma-Aldrich) or 10 µg/ml LPS, 10 µg/ml anti- (Jackson Immuno-
Research Laboratories, Inc.), or 500 ng/ml anti-CD40 (eBioscience), alone 
or in combination with 40 ng/ml IL-4 (R&D Systems). Tritiated thymidine 
(PerkinElmer) was added at day 3, and incorporation was assayed after 15–18 h. 
Supernatants from in vitro Ig experiments were analyzed by ELISA on day 6. 
Aicda and Prdm1 mRNA expression was assessed by PCR on RNA extracted 
from 4-d-cultured naive B cells either in medium or plus 10 µg/ml 
LPS using TaqMan probes. For BAFF-induced responses, naive B cells were 
prepared from splenocytes by negative selection using a cocktail of biotin-
conjugated mAbs to CD43, CD11b, Thy1.2, CD138, IgG1, IgG2a, IgG2b, 
IgG3, IgA, and IgE (BD) and streptavidin magnetic beads (Invitrogen). 
Naive B cells were cultured in medium alone or in the presence of 1 mg/ml 
sBAFF (Alexis) or 50 ng/ml sBAFF + IL-4. To assess cell viability, cells were 
counted at day 4 in the presence of trypan blue (Sigma-Aldrich), and the 
percentage of live cells was determined. IgG1 secretion in supernatants was 
analyzed by ELISA on day 7.
In vitro T helper cell differentiation. For Th0 conditions, naive CD4+ 
T cells were sorted by MACS and were stimulated for 5 d with plate-bound 
antibodies against CD3 (145-2C11; 2 µg/ml; eBioscience) and CD28 (PV-1; 2 
µg/ml; BioLegend). For Th2 cell differentiation, 50 ng/ml IL-4 (BioLeg-
end) and 10 µg/ml neutralizing anti–IFN- mAb (XMG 1.2; BioLegend) 
were added. For Th17 cell differentiation, 40 ng/ml IL-6 (BioLegend), 
40ng/ml IL-23 (R&D Systems), 1 ng/ml TGF- (BioLegend), 10 µg/ml 
anti–IL-4 (11B11; BioLegend), and 10 µg/ml anti–IFN- (XMG1.2; Bio-
Legend) neutralizing antibodies were added. For Th1 cell differentiation, 
5 ng/ml IL-12 (BioLegend) and 10 µg/ml anti–IL-4 neutralizing mAbs 
(11B11; BioLegend) were added.
Serum Ig levels and antibody responses. 4–6-wk-old mice were immu-
nized i.p. with 50 µg OVA with Alum (Sigma-Aldrich) in PBS at day 0, 
boosted at day 14, and bled at days 0 and 21. Mice were immunized i.p. with 
25 µg TNP-LPS (Biosearch Technologies) in PBS or with 25 µg TNP–Ficoll 
(Biosearch Technologies) at day 0 and bled at days 0 and 14. Antigen-specific 
antibody responses were analyzed by OVA- or TNP-specific ELISA using 
96-well plates coated with either OVA- or TNP-conjugated BSA (Biosearch 
Technologies) at 10 µg/ml in PBS. For serum Ig levels, plates were coated with 
isotype-specific antibodies (SouthernBiotech). AP-conjugated secondary anti-
bodies (SouthernBiotech) and PNPP (Sigma-Aldrich) were used for ELISA.
cages with trimethoprim/sulfamethoxazole and enrofloxacin added to the water 
to prevent infection. Procedures were performed in accordance with the Animal 
Care and Use Committee of the Children’s Hospital Boston.
Dermal fibroblast isolation and culture. Primary dermal fibroblasts were 
isolated as in McDonald et al. (2007) and grown in RPMI media plus 10% 
FCS (Hyclone) plus l-glutamine, penicillin, and streptomycin (Invitrogen). 
Fibroblasts were stimulated with media, 10 ng/ml IL-1, 10 ng/ml TNF 
(R&D Systems), or 1 mg/ml LPS (Sigma-Aldrich) for the indicated times.
Western blotting. Western blotting was performed as previously described 
(McDonald et al., 2007) using anti–phospho IB (Cell Signaling Technol-
ogy), anti–mouse full-length IB (Abcam), and anti-actin (Sigma-Aldrich) 
according to the manufacturers’ recommendations. Immunoblotting was also 
performed using anti-p100/p52, RelB, and NIK (Cell Signaling Technol-
ogy). Sheep anti–mouse horseradish peroxidase–conjugated and sheep anti–
rabbit horseradish peroxidase–conjugated secondary antibodies were obtained 
from GE Healthcare. Quantification was performed using the public domain 
ImageJ/FIJI software from the National Institutes of Health.
BMDC isolation and TLR ligand stimulation. BM was flushed from 
the femur and tibia of 6–8-wk-old mice, plated in DMEM (Gibco) plus 10% 
FCS and plus l-glutamine, penicillin, and streptomycin, 10 ng/ml GM-CSF, 
and 10 ng/ml IL-4. Cells were washed at day 1, replated at day 7, and used 
for experiments between days 8 and 12. The DC phenotype was confirmed 
by flow cytometry for CD11c and MHCII and negative for Ly6G. The TLR 
ligands PAM3CSK4 (TLR1/2), ultrapure LPS from Salmonella minnesota 
(TLR4), loxoribine (TLR7), and CpG DNA (ODN1826; TLR9) were ob-
tained from InvivoGen.
MEF isolation and culture. Primary MEFs were isolated as in Xu (2005) 
and grown in DMEM plus 10% FCS and plus l-glutamine, penicillin, 
and streptomycin.
VCAM1 surface staining. MEFs were treated for 24 h with 10 ng/ml TNF, 
dissociated with trypsin/EDTA, and stained with anti-VCAM1 (eBioscience).
LN detection by Evan’s blue injection. LN detection was performed as 
described in Harrell et al. (2008).
H&E staining. Samples of inguinal fat pad, small intestine, nasal cavity, 
thymus, spleen, and LN were fixed in formalin for 24 h, and then H&E 
staining of paraffin-embedded cut sections was performed by the Rodent 
Histopathology and Specialized Histopathology Services cores at the Dana 
Farber/Harvard Cancer Center (Boston, MA) or by Histo-Scientific Re-
search Laboratories (HSRL, Mt. Jackson, Virginia).
Complete blood counts (CBCs). Blood was collected from the facial 
vein, and CBC analysis was performed by the Animal Research at Children’s 
Hospital (ARCH) facility.
FACS analysis. Single-cell suspensions from spleen, thymus, or BM of 
4–6-wk-old mice were stained with FITC, PE, PE-Cy7, APC, PerCP-Cy5.5, 
Alexa Fluor 700, or APC–eFluor 780–labeled mAbs and analyzed on a 
FACSCanto (BD). Antibodies to B220, CD3, IgM, CD21, CD23, CD93, 
CD43, CD4, CD8, GL-7, CD11b, Ly6G, F4/80, NK1.1, CD45, IL7-R, 
CD45.1, and CD45.2 were from eBioscience, mAb to Fas was from BD, 
and FITC-conjugated PNA was from Sigma-Aldrich.
Immunofluorescence. Immunofluorescence was performed as described 
in Cariappa et al. (2009) and Kranich et al. (2008).
LTi cell isolation from embryonic intestine. Embryonic intestines were 
isolated from E17.5 fetuses, incubated in Liberase (Roche) for 1 h at 37°C, 
and then passed through a 70-µm filter. A portion of the embryos was re-
served for genotyping.
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CHS to OXA. Mice were sensitized by the application of 100 µl of 2% OXA 
(Sigma-Aldrich) in ethanol on day 1 to shaved abdominal skin. On day 5, the 
left ear was challenged with 10 µl of 1% OXA, and the right ear was challenged 
with vehicle (ethanol) on dorsal and ventral surfaces. Ear thickness was mea-
sured after 24 h with a micrometer (Mitutoyo).
BM reconstitution of mutant mice. Adult healthy mutant mice and their 
WT littermates received two 550-cGy (137Cesium source) doses of total body 
irradiation 3 h apart. BM was collected from CD45.1 mice (Charles River), and 
105 viable BM cells were injected i.v. into the mice. Reconstitution was assessed 
by flow cytometry using antibodies to CD45.1 (donor) and CD45.2 (recipient).
BM reconstitution of Rag2/ mice. BM was collected from 6-wk-old 
mutant mice or their WT littermates. Flow cytometry was performed to assure 
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Double-positive cells were collected at the Children’s Hospital cell sorting core.
Statistical analysis. Statistical analysis of data was performed with Prism soft-
ware (GraphPad Software) using the Student’s t test or ANOVA.
Online supplemental material. Fig. S1 shows the Nfkbia targeting construct 
and screening strategy. Online supplemental material is available at http://
www.jem.org/cgi/content/full/jem.20140979/DC1.
We thank Dr. Talal Chatila for critical reading of the manuscript, the members of 
the Geha laboratory for support, and Drs. Shiv Pillai, Luigi Notarangelo, and Koichi 
Kobayashi for their advice.
This work was supported by National Institutes of Health (NIH) grants 
5P01AI076210 and 5T32-AI007512 to R.S. Geha and by a Talecris fellowship  
to J.L. Mooster.
The authors declare no competing financial interests.
Submitted: 22 May 2014
Accepted: 23 December 2014
REFERENCES
Alcamo, E., N. Hacohen, L.C. Schulte, P.D. Rennert, R.O. Hynes, and D. 
Baltimore. 2002. Requirement for the NF-B family member RelA in 
the development of secondary lymphoid organs. J. Exp. Med. 195:233–
244. http://dx.doi.org/10.1084/jem.20011885
Alimzhanov, M.B., D.V. Kuprash, M.H. Kosco-Vilbois, A. Luz, R.L. 
Turetskaya, A. Tarakhovsky, K. Rajewsky, S.A. Nedospasov, and K. Pfeffer. 
1997. Abnormal development of secondary lymphoid tissues in lympho-
toxin -deficient mice. Proc. Natl. Acad. Sci. USA. 94:9302–9307. http://
dx.doi.org/10.1073/pnas.94.17.9302
Balázs, M., F. Martin, T. Zhou, and J. Kearney. 2002. Blood dendritic cells 
interact with splenic marginal zone B cells to initiate T-independent 
immune responses. Immunity. 17:341–352. http://dx.doi.org/10.1016/ 
S1074-7613(02)00389-8
Banks, T.A., B.T. Rouse, M.K. Kerley, P.J. Blair, V.L. Godfrey, N.A. Kuklin, D.M. 
Bouley, J. Thomas, S. Kanangat, and M.L. Mucenski. 1995. Lymphotoxin-
alpha-deficient mice. Effects on secondary lymphoid organ development 
and humoral immune responsiveness. J. Immunol. 155:1685–1693.
Batten, M., J. Groom, T.G. Cachero, F. Qian, P. Schneider, J. Tschopp, 
J.L. Browning, and F. Mackay. 2000. BAFF mediates survival of peripheral 
immature B lymphocytes. J. Exp. Med. 192:1453–1466. http://dx.doi 
.org/10.1084/jem.192.10.1453
Bénézech, C., A. White, E. Mader, K. Serre, S. Parnell, K. Pfeffer, C.F. Ware, G. 
Anderson, and J.H. Caamaño. 2010. Ontogeny of stromal organizer cells 
during lymph node development. J. Immunol. 184:4521–4530. http://
dx.doi.org/10.4049/jimmunol.0903113
JEM Vol. 212, No. 2
Article
201
Koni, P.A., R. Sacca, P. Lawton, J.L. Browning, N.H. Ruddle, and R.A. 
Flavell. 1997. Distinct roles in lymphoid organogenesis for lympho-
toxins  and  revealed in lymphotoxin –deficient mice. Immunity. 
6:491–500. http://dx.doi.org/10.1016/S1074-7613(00)80292-7
Körner, H., M. Cook, D.S. Riminton, F.A. Lemckert, R.M. Hoek, B. 
Ledermann, F. Köntgen, B. Fazekas de St Groth, and J.D. Sedgwick. 
1997. Distinct roles for lymphotoxin- and tumor necrosis factor in or-
ganogenesis and spatial organization of lymphoid tissue. Eur. J. Immunol. 
27:2600–2609. http://dx.doi.org/10.1002/eji.1830271020
Kranich, J., N.J. Krautler, E. Heinen, M. Polymenidou, C. Bridel, A. 
Schildknecht, C. Huber, M.H. Kosco-Vilbois, R. Zinkernagel, G. 
Miele, and A. Aguzzi. 2008. Follicular dendritic cells control engulf-
ment of apoptotic bodies by secreting Mfge8. J. Exp. Med. 205:1293–
1302. http://dx.doi.org/10.1084/jem.20071019
Laurikkala, J., J. Pispa, H.S. Jung, P. Nieminen, M. Mikkola, X. Wang, 
U. Saarialho-Kere, J. Galceran, R. Grosschedl, and I. Thesleff. 2002. 
Regulation of hair follicle development by the TNF signal ectodysplasin 
and its receptor Edar. Development. 129:2541–2553.
Liptay, S., R.M. Schmid, E.G. Nabel, and G.J. Nabel. 1994. Transcriptional 
regulation of NF-kappa B2: evidence for kappa B-mediated positive and 
negative autoregulation. Mol. Cell. Biol. 14:7695–7703.
Lo, J.C., S. Basak, E.S. James, R.S. Quiambo, M.C. Kinsella, M.L. Alegre, 
F. Weih, G. Franzoso, A. Hoffmann, and Y.X. Fu. 2006. Coordination 
between NF-B family members p50 and p52 is essential for mediating 
LTR signals in the development and organization of secondary lym-
phoid tissues. Blood. 107:1048–1055. http://dx.doi.org/10.1182/blood- 
2005-06-2452
Lopez-Granados, E., J.E. Keenan, M.C. Kinney, H. Leo, N. Jain, C.A. Ma, 
R. Quinones, E.W. Gelfand, and A. Jain. 2008. A novel mutation in 
NFKBIA/IKBA results in a degradation-resistant N-truncated protein 
and is associated with ectodermal dysplasia with immunodeficiency. 
Hum. Mutat. 29:861–868. http://dx.doi.org/10.1002/humu.20740
Matsumoto, M., Y.X. Fu, H. Molina, G. Huang, J. Kim, D.A. Thomas, 
M.H. Nahm, and D.D. Chaplin. 1997. Distinct roles of lymphotoxin  
and the type I tumor necrosis factor (TNF) receptor in the establishment 
of follicular dendritic cells from non–bone marrow–derived cells. J. Exp. 
Med. 186:1997–2004. http://dx.doi.org/10.1084/jem.186.12.1997
Matsushima, A., T. Kaisho, P.D. Rennert, H. Nakano, K. Kurosawa, D. 
Uchida, K. Takeda, S. Akira, and M. Matsumoto. 2001. Essential role of 
nuclear factor (NF)-B–inducing kinase and inhibitor of B (IB) kinase 
 in NF-B activation through lymphotoxin  receptor, but not through 
tumor necrosis factor receptor I. J. Exp. Med. 193:631–636. http://dx 
.doi.org/10.1084/jem.193.5.631
McDonald, D.R., J.L. Mooster, M. Reddy, E. Bawle, E. Secord, and R.S. Geha. 
2007. Heterozygous N-terminal deletion of IB results in functional 
nuclear factor B haploinsufficiency, ectodermal dysplasia, and immune 
deficiency. J. Allergy Clin. Immunol. 120:900–907. http://dx.doi.org/ 
10.1016/j.jaci.2007.08.035
Mebius, R.E. 2003. Organogenesis of lymphoid tissues. Nat. Rev. Immunol. 
3:292–303. http://dx.doi.org/10.1038/nri1054
Miyawaki, S., Y. Nakamura, H. Suzuka, M. Koba, R. Yasumizu, S. Ikehara, 
and Y. Shibata. 1994. A new mutation, aly, that induces a generalized 
lack of lymph nodes accompanied by immunodeficiency in mice. Eur. J. 
Immunol. 24:429–434. http://dx.doi.org/10.1002/eji.1830240224
Napetschnig, J., and H. Wu. 2013. Molecular basis of NF-B signaling. 
Annu. Rev. Biophys. 42:443–468. http://dx.doi.org/10.1146/annurev- 
biophys-083012-130338
Ohnishi, H., R. Miyata, T. Suzuki, T. Nose, K. Kubota, Z. Kato, H. Kaneko, and 
N. Kondo. 2012. A rapid screening method to detect autosomal-dominant 
ectodermal dysplasia with immune deficiency syndrome. J. Allergy Clin. 
Immunol. 129:578–580. http://dx.doi.org/10.1016/j.jaci.2011.09.042
Okamoto, N., R. Chihara, C. Shimizu, S. Nishimoto, and T. Watanabe. 2007. 
Artificial lymph nodes induce potent secondary immune responses in 
naive and immunodeficient mice. J. Clin. Invest. 117:997–1007. http://
dx.doi.org/10.1172/JCI30379
Orange, J.S., and R.S. Geha. 2003. Finding NEMO: genetic disorders of 
NF-B activation. J. Clin. Invest. 112:983–985. http://dx.doi.org/10 
.1172/JCI19960
 (LT) relies on internalization of LT receptor. Mol. Cell. Biol. 
31:4319–4334. http://dx.doi.org/10.1128/MCB.05033-11
Gorbachev, A.V., and R.L. Fairchild. 2004. CD4+ T cells regulate CD8+ 
T cell-mediated cutaneous immune responses by restricting effector T cell 
development through a Fas ligand-dependent mechanism. J. Immunol. 
172:2286–2295. http://dx.doi.org/10.4049/jimmunol.172.4.2286
Gray, C.M., C. Remouchamps, K.A. McCorkell, L.A. Solt, E. Dejardin, J.S. 
Orange, and M.J. May. 2014. Noncanonical NF-B signaling is limited 
by classical NF-B activity. Sci. Signal. 7:ra13. http://dx.doi.org/10 
.1126/scisignal.2004557
Hanson, E.P., L. Monaco-Shawver, L.A. Solt, L.A. Madge, P.P. Banerjee, 
M.J. May, and J.S. Orange. 2008. Hypomorphic nuclear factor-B 
essential modulator mutation database and reconstitution system identifies 
phenotypic and immunologic diversity. J. Allergy Clin. Immunol. 122: 
1169–1177: e16. http://dx.doi.org/10.1016/j.jaci.2008.08.018
Harrell, M.I., B.M. Iritani, and A. Ruddell. 2008. Lymph node mapping 
in the mouse. J. Immunol. Methods. 332:170–174. http://dx.doi.org/10 
.1016/j.jim.2007.11.012
Hayden, M.S., and S. Ghosh. 2008. Shared principles in NF-B signaling. 
Cell. 132:344–362. http://dx.doi.org/10.1016/j.cell.2008.01.020
Hayden, M.S., and S. Ghosh. 2012. NF-B, the first quarter-century: re-
markable progress and outstanding questions. Genes Dev. 26:203–234. 
http://dx.doi.org/10.1101/gad.183434.111
Hayden, M.S., A.P. West, and S. Ghosh. 2006. NF-B and the im-
mune response. Oncogene. 25:6758–6780. http://dx.doi.org/10.1038/ 
sj.onc.1209943
Hoffmann, A., T.H. Leung, and D. Baltimore. 2003. Genetic analysis of 
NF-B/Rel transcription factors defines functional specificities. EMBO 
J. 22:5530–5539. http://dx.doi.org/10.1093/emboj/cdg534
Imamura, M., T. Kawai, S. Okada, K. Izawa, T. Takachi, H. Iwabuchi, S. Yoshida, 
R. Hosokai, H. Kanegane, T. Yamamoto, et al. 2011. Disseminated BCG 
infection mimicking metastatic nasopharyngeal carcinoma in an immuno-
deficient child with a novel hypomorphic NEMO mutation. J. Clin. 
Immunol. 31:802–810. http://dx.doi.org/10.1007/s10875-011-9568-9
Janssen, R., A. van Wengen, M.A. Hoeve, M. ten Dam, M. van der Burg, J. 
van Dongen, E. van de Vosse, M. van Tol, R. Bredius, T.H. Ottenhoff, 
et al. 2004. The same IB mutation in two related individuals leads 
to completely different clinical syndromes. J. Exp. Med. 200:559–568. 
http://dx.doi.org/10.1084/jem.20040773
Karin, M., and Y. Ben-Neriah. 2000. Phosphorylation meets ubiquitina-
tion: the control of NF-B activity. Annu. Rev. Immunol. 18:621–663. 
http://dx.doi.org/10.1146/annurev.immunol.18.1.621
Kawai, T., R. Nishikomori, and T. Heike. 2012. Diagnosis and treatment 
in anhidrotic ectodermal dysplasia with immunodeficiency. Allergol. Int. 
61:207–217.
Kere, J., A.K. Srivastava, O. Montonen, J. Zonana, N. Thomas, B. Ferguson, 
F. Munoz, D. Morgan, A. Clarke, P. Baybayan, et al. 1996. X-linked 
anhidrotic (hypohidrotic) ectodermal dysplasia is caused by mutation in a 
novel transmembrane protein. Nat. Genet. 13:409–416. http://dx.doi.org/ 
10.1038/ng0895-409
Kim, D., R.E. Mebius, J.D. MacMicking, S. Jung, T. Cupedo, Y. 
Castellanos, J. Rho, B.R. Wong, R. Josien, N. Kim, et al. 2000. 
Regulation of peripheral lymph node genesis by the tumor necrosis fac-
tor family member TRANCE. J. Exp. Med. 192:1467–1478. http://
dx.doi.org/10.1084/jem.192.10.1467
Koduru, S., L. Kumar, M.J. Massaad, N. Ramesh, S. Le Bras, E. Ozcan, M.K. 
Oyoshi, M. Kaku, Y. Fujiwara, L. Kremer, et al. 2010. Cdc42 interacting 
protein 4 (CIP4) is essential for integrin-dependent T-cell trafficking. 
Proc. Natl. Acad. Sci. USA. 107:16252–16256. http://dx.doi.org/10.1073/ 
pnas.1002747107
Koike, R., T. Nishimura, R. Yasumizu, H. Tanaka, Y. Hataba, Y. Hataba, 
T. Watanabe, S. Miyawaki, and M. Miyasaka. 1996. The splenic mar-
ginal zone is absent in alymphoplastic aly mutant mice. Eur. J. Immunol. 
26:669–675. http://dx.doi.org/10.1002/eji.1830260324
Kong, Y.Y., H. Yoshida, I. Sarosi, H.L. Tan, E. Timms, C. Capparelli, S. 
Morony, A.J. Oliveira-dos-Santos, G. Van, A. Itie, et al. 1999. OPGL is a 
key regulator of osteoclastogenesis, lymphocyte development and lymph-
node organogenesis. Nature. 397:315–323. http://dx.doi.org/10.1038/ 
16852
202 Defective lymphoid organogenesis in AD ED-ID | Mooster et al.
Srivastava, A.K., M.C. Durmowicz, A.J. Hartung, J. Hudson, L.V. Ouzts, D.M. 
Donovan, C.Y. Cui, and D. Schlessinger. 2001. Ectodysplasin-A1 is suffi-
cient to rescue both hair growth and sweat glands in Tabby mice. Hum. Mol. 
Genet. 10:2973–2981. http://dx.doi.org/10.1093/hmg/10.26.2973
Tsitsikov, E.N., J.C. Gutierrez-Ramos, and R.S. Geha. 1997. Impaired CD19 
expression and signaling, enhanced antibody response to type II T in-
dependent antigen and reduction of B-1 cells in CD81-deficient mice. 
Proc. Natl. Acad. Sci. USA. 94:10844–10849. http://dx.doi.org/10.1073/ 
pnas.94.20.10844
Tucker, E., K. O’Donnell, M. Fuchsberger, A.A. Hilton, D. Metcalf, K. 
Greig, N.A. Sims, J.M. Quinn, W.S. Alexander, D.J. Hilton, et al. 2007. 
A novel mutation in the Nfkb2 gene generates an NF-B2 “super repres-
sor”. J. Immunol. 179:7514–7522. http://dx.doi.org/10.4049/jimmunol 
.179.11.7514
Tumanov, A.V., S.I. Grivennikov, A.N. Shakhov, S.A. Rybtsov, E.P. 
Koroleva, J. Takeda, S.A. Nedospasov, and D.V. Kuprash. 2003. 
Dissecting the role of lymphotoxin in lymphoid organs by conditional 
targeting. Immunol. Rev. 195:106–116. http://dx.doi.org/10.1034/
j.1600-065X.2003.00071.x
van de Pavert, S.A., and R.E. Mebius. 2010. New insights into the devel-
opment of lymphoid tissues. Nat. Rev. Immunol. 10:664–674. http://
dx.doi.org/10.1038/nri2832
van de Pavert, S.A., B.J. Olivier, G. Goverse, M.F. Vondenhoff, M. 
Greuter, P. Beke, K. Kusser, U.E. Höpken, M. Lipp, K. Niederreither, 
et al. 2009. Chemokine CXCL13 is essential for lymph node initiation 
and is induced by retinoic acid and neuronal stimulation. Nat. Immunol. 
10:1193–1199. http://dx.doi.org/10.1038/ni.1789
Vondenhoff, M.F., M. Greuter, G. Goverse, D. Elewaut, P. Dewint, C.F. 
Ware, K. Hoorweg, G. Kraal, and R.E. Mebius. 2009. LTR signaling 
induces cytokine expression and up-regulates lymphangiogenic factors in 
lymph node anlagen. J. Immunol. 182:5439–5445. http://dx.doi.org/10 
.4049/jimmunol.0801165
Wang, B., H. Fujisawa, L. Zhuang, I. Freed, B.G. Howell, S. Shahid, G.M. 
Shivji, T.W. Mak, and D.N. Sauder. 2000. CD4+ Th1 and CD8+ type 
1 cytotoxic T cells both play a crucial role in the full development of 
contact hypersensitivity. J. Immunol. 165:6783–6790. http://dx.doi.org/ 
10.4049/jimmunol.165.12.6783
Ware, C.F., T.L. VanArsdale, P.D. Crowe, and J.L. Browning. 1995. The 
ligands and receptors of the lymphotoxin system. Curr. Top. Microbiol. 
Immunol. 198:175–218.
Weih, F., D. Carrasco, S.K. Durham, D.S. Barton, C.A. Rizzo, R.P. Ryseck, 
S.A. Lira, and R. Bravo. 1995. Multiorgan inflammation and hemato-
poietic abnormalities in mice with a targeted disruption of RelB, a mem-
ber of the NF-B/Rel family. Cell. 80:331–340. http://dx.doi.org/10 
.1016/0092-8674(95)90416-6
Weih, D.S., Z.B. Yilmaz, and F. Weih. 2001. Essential role of RelB in 
germinal center and marginal zone formation and proper expression of 
homing chemokines. J. Immunol. 167:1909–1919. http://dx.doi.org/10 
.4049/jimmunol.167.4.1909
Winning, S., F. Splettstoesser, J. Fandrey, and S. Frede. 2010. Acute hypoxia in-
duces HIF-independent monocyte adhesion to endothelial cells through 
increased intercellular adhesion molecule-1 expression: the role of hypoxic 
inhibition of prolyl hydroxylase activity for the induction of NF-B. 
J. Immunol. 185:1786–1793. http://dx.doi.org/10.4049/jimmunol.0903244
Xu, J. 2005. Preparation, culture, and immortalization of mouse embryonic 
fibroblasts. Curr. Protoc. Mol. Biol. Chapter 28:Unit 28.1. http://dx.doi 
.org/10.1002/0471142727.mb2801s70
Yoshioka, T., R. Nishikomori, J. Hara, K. Okada, Y. Hashii, I. Okafuji, S. 
Nodomi, T. Kawai, K. Izawa, H. Ohnishi, et al. 2013. Autosomal dom-
inant anhidrotic ectodermal dysplasia with immunodeficiency caused by 
a novel NFKBIA mutation, p.Ser36Tyr, presents with mild ectodermal 
dysplasia and non-infectious systemic inflammation. J. Clin. Immunol. 
33:1165–1174. http://dx.doi.org/10.1007/s10875-013-9924-z
Orange, J.S., A. Jain, Z.K. Ballas, L.C. Schneider, R.S. Geha, and F.A. 
Bonilla. 2004. The presentation and natural history of immunodeficiency 
caused by nuclear factor B essential modulator mutation. J. Allergy Clin. 
Immunol. 113:725–733. http://dx.doi.org/10.1016/j.jaci.2004.01.762
Orange, J.S., O. Levy, and R.S. Geha. 2005. Human disease resulting from gene mu-
tations that interfere with appropriate nuclear factor-B activation. Immunol. 
Rev. 203:21–37. http://dx.doi.org/10.1111/j.0105-2896.2005.00221.x
Pasparakis, M., L. Alexopoulou, V. Episkopou, and G. Kollias. 1996. Immune 
and inflammatory responses in TNF alpha-deficient mice: a critical re-
quirement for TNF alpha in the formation of primary B cell follicles, 
follicular dendritic cell networks and germinal centers, and in the matu-
ration of the humoral immune response. J. Exp. Med. 184:1397–1411. 
http://dx.doi.org/10.1084/jem.184.4.1397
Pasparakis, M., L. Alexopoulou, M. Grell, K. Pfizenmaier, H. Bluethmann, and 
G. Kollias. 1997. Peyer’s patch organogenesis is intact yet formation of 
B lymphocyte follicles is defective in peripheral lymphoid organs of mice 
deficient for tumor necrosis factor and its 55-kDa receptor. Proc. Natl. Acad. 
Sci. USA. 94:6319–6323. http://dx.doi.org/10.1073/pnas.94.12.6319
Picard, C., J.L. Casanova, and A. Puel. 2011. Infectious diseases in patients 
with IRAK-4, MyD88, NEMO, or IB deficiency. Clin. Microbiol. 
Rev. 24:490–497. http://dx.doi.org/10.1128/CMR.00001-11
Pillai, S., A. Cariappa, and S.T. Moran. 2005. Marginal zone B cells. Annu. Rev. 
Immunol. 23:161–196. http://dx.doi.org/10.1146/annurev.immunol.23 
.021704.115728
Puel, A., C. Picard, C.L. Ku, A. Smahi, and J.L. Casanova. 2004. Inherited 
disorders of NF-B-mediated immunity in man. Curr. Opin. Immunol. 
16:34–41. http://dx.doi.org/10.1016/j.coi.2003.11.013
Rajewsky, K. 1996. Clonal selection and learning in the antibody system. 
Nature. 381:751–758. http://dx.doi.org/10.1038/381751a0
Rennert, P.D., J.L. Browning, R. Mebius, F. Mackay, and P.S. Hochman. 
1996. Surface lymphotoxin alpha/beta complex is required for the de-
velopment of peripheral lymphoid organs. J. Exp. Med. 184:1999–2006. 
http://dx.doi.org/10.1084/jem.184.5.1999
Rennert, P.D., P.S. Hochman, R.A. Flavell, D.D. Chaplin, S. Jayaraman, 
J.L. Browning, and Y.X. Fu. 2001. Essential role of lymph nodes in con-
tact hypersensitivity revealed in lymphotoxin-–deficient mice. J. Exp. 
Med. 193:1227–1238. http://dx.doi.org/10.1084/jem.193.11.1227
Roozendaal, R., and R.E. Mebius. 2011. Stromal cell-immune cell interactions. 
Annu. Rev. Immunol. 29:23–43. http://dx.doi.org/10.1146/annurev- 
immunol-031210-101357
Schimke, L.F., N. Rieber, S. Rylaarsdam, O. Cabral-Marques, N. Hubbard, 
A. Puel, L. Kallmann, S.A. Sombke, G. Notheis, H.P. Schwarz, et al. 2013. 
A novel gain-of-function IKBA mutation underlies ectodermal dyspla-
sia with immunodeficiency and polyendocrinopathy. J. Clin. Immunol. 
33:1088–1099. http://dx.doi.org/10.1007/s10875-013-9906-1
Seymour, R., J.P. Sundberg, and H. Hogenesch. 2006. Abnormal lymphoid 
organ development in immunodeficient mutant mice. Vet. Pathol. 43: 
401–423. http://dx.doi.org/10.1354/vp.43-4-401
Shih, V.F., R. Tsui, A. Caldwell, and A. Hoffmann. 2011. A single NFB 
system for both canonical and non-canonical signaling. Cell Res. 21:86–
102. http://dx.doi.org/10.1038/cr.2010.161
Shinkura, R., K. Kitada, F. Matsuda, K. Tashiro, K. Ikuta, M. Suzuki, K. 
Kogishi, T. Serikawa, and T. Honjo. 1999. Alymphoplasia is caused by 
a point mutation in the mouse gene encoding Nf-b-inducing kinase. 
Nat. Genet. 22:74–77. http://dx.doi.org/10.1038/8780
Shultz, D.B., M.R. Rani, J.D. Fuller, R.M. Ransohoff, and G.R. Stark. 
2009. Roles of IKK-, IRF1, and p65 in the activation of chemokine 
genes by interferon-. J. Interferon Cytokine Res. 29:817–824. http://
dx.doi.org/10.1089/jir.2009.0034
Snapper, C.M., P. Zelazowski, F.R. Rosas, M.R. Kehry, M. Tian, D. 
Baltimore, and W.C. Sha. 1996. B cells from p50/NF-kappa B knock-
out mice have selective defects in proliferation, differentiation, germ-
line CH transcription, and Ig class switching. J. Immunol. 156:183–191.
